Clinical Trial Update: Avapritinib in the Treatment of Unresectable or Recurrent Metastatic GIST Non-exon18 Mutations of PDGFRA

View source ↗

Summary

This clinical trial update covers the investigation of avapritinib for unresectable or recurrent/metastatic gastrointestinal stromal tumors with non-exon 18 PDG…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Stromal Tumor

Drugs mentioned

• Avapritinib (avapritinib)

Snippet

Sponsor: Xinhua Zhang, MD | Conditions: Gastrointestinal Stromal Tumors, Unresectable Solid Tumor | Status: RECRUITING